Advertisement
Home »

Sunitinib Vs. Interferon Alfa in Patients with Metastatic RCC: Overall Survival and Updated Results

May 05, 2023

ABOUT THE CONTRIBUTORS

Author

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


RECOMMENDED ARTICLES FOR YOU

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RECOMMENDED ARTICLES FOR YOU

Advertisement